Finally, as illustrated in Fig. 7G, we propose a working model in which EIF2B4 interacts with the eIF2α translation initiation complex and binds the STAT3 5′UTR to promote its translation in a GEF-dependent manner, ultimately driving oncogenic progression and immune resistance in HCC. This evidence concerns the gene EIF2B4 and hepatocellular carcinoma.